ArticlePLoS computational biology2026
A novel transformer-based platform for the prediction and design of biosynthetic gene clusters for (un)natural products.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A foundation model enables prediction of natural product molecular properties, bioactivity, and structural similarity from biosynthetic gene cluster sequence.bioRxiv : the preprint server for biology · 2026Article
- Bacterial proteome foundation model enhances functional prediction from enzymes to ecological interactions.bioRxiv : the preprint server for biology · 2026Article
- A comprehensive review on bacterial endophytic secondary metabolites: a road map from crude extract to lead molecule production.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosynthetic gene clusters (BGCs), comprising sets of functionally related genes responsible for synthesizing complex natural products, are a rich source of bioactive compounds with pharmaceutical potential. Here, we present a transformer-based framework that models functional domains as linguistic units to capture and predict their positional relationships within genomes. Using a RoBERTa architecture, we trained models on four progressively broader datasets: bacterial BGCs, Actinomycetes genomes, bacterial genomes, and bacterial plus fungal genomes. Evaluation using 2,492 experimentally-validated BGCs from the MIBiG database showed that more than 50% of true domains were ranked first and over 75% within the top 10 candidates. Our models also achieved classification accuracies exceeding 70% for major compound classes including polyketides (PKs) and terpenes. To explore model-guided BGC design, we compared predictions from the BGC-trained and genome-trained models using the BGC for the bacterial diterpenoid cyclooctatin as a case study. The genome-trained model uniquely predicted several domains absent from both the original BGC and the prediction by the BGC-trained model. Heterologous expression of one of those predicted domains in Streptomyces albus, together with the biosynthetic genes for cyclooctatin, yielded an unknown cyclooctatin derivative. This framework not only provides a novel BGC prediction method using machine learning but also facilitates rational design of artificial BGCs. Future integration of transcriptomic, protein structural, and phylogenetic data will enhance the models' predictive and generative capabilities, supporting accelerated discovery and engineering of natural products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.